Prodrugs based on pyridoxine and ketorolac (the most potent analgesic NSAIDs) exhibit analgesic activity comparable to ketorolac in vivo and significantly higher safety and prolonged action. In this study the antioxidant and protective properties, inhibitory activity against cyclooxygenase (COX) and intracellular permeability for two prodrug bipharmacophoric conjugates based on pyridoxine and ketorolac have been investigated in vitro. Their inhibitory activity towards the COX-1 and COX-2 enzymes was comparable to that of ketorolac (the IC50 values ranged from 12.0 μM to 34.7 μM). These compounds markedly protected albumin against thermal and chemical (urea and citric acid) treatments and demonstrated the cell-penetrating ability through passive diffusion.
Agafonova M.N., Vasileva O.S., Fafanova E.M., Grishaev D.J., Sarynin M.N., Pugachev M.V., Shtyrlin Yu.G. (2025) In vitro biological properties of pyridoxine and ketorolac conjugates. Biomeditsinskaya Khimiya, 71(6), 432-440.
Agafonova M.N. et al. In vitro biological properties of pyridoxine and ketorolac conjugates // Biomeditsinskaya Khimiya. - 2025. - V. 71. -N 6. - P. 432-440.
Agafonova M.N. et al., "In vitro biological properties of pyridoxine and ketorolac conjugates." Biomeditsinskaya Khimiya 71.6 (2025): 432-440.
Agafonova, M. N., Vasileva, O. S., Fafanova, E. M., Grishaev, D. J., Sarynin, M. N., Pugachev, M. V., Shtyrlin, Yu. G. (2025). In vitro biological properties of pyridoxine and ketorolac conjugates. Biomeditsinskaya Khimiya, 71(6), 432-440.
References
Karateev A.E. (2011) Ketorolac in clinical practice. Neurology, Neuropsychiatry, Psychosomatics, 3(4), 81–89. CrossRef Scholar google search
Matveev A.V., Krasheninnikov A.E., Egorova E.A. (2018) Modern view on the efficacy and safety of ketorolac. RMJ. Medical Review, 2(4), 34–39. Scholar google search
Cepeda M.S., Carr D.B., Miranda N., Diaz A., Silva C., Morales O. (2005) Comparison of morphine, ketorolac, and their combination for postoperative pain: results from a large, randomized, double-blind trial. Anesthesiology, 103(6), 1225–1232. CrossRef Scholar google search
Zhuravleva M.V., Kukes V.G., Prokofiev A.B., Serebrova S.Yu., Gorodetskaya G.I., Berdnikova N.G. (2016) Rational use of NSAIDs — balance of efficiency and safety (review). International Journal of Applied and Fundamental Research, 6(4), 687–696. Scholar google search
Grigorovich R.I., Nemakhova E.A., Lavrentiev A.A., Popov P.A. (2010) NAID: anesthesiology effectiveness and basis of safe using (review of literature). Journal of New Medical Technologies, 17(2), 175–179. Scholar google search
Karateev A.E., Aleynikova T.L. (2016) Eicosanoids and inflammation. Modern Rheumatology Journal, 10(4), 73–86. CrossRef Scholar google search
Drini M. (2017) Peptic ulcer disease and non-steroidal anti-inflammatory drugs. Australian Prescriber, 40(3), 91–93. CrossRef Scholar google search
Sohail R., Mathew M., Patel K.K., Reddy S.A., Haider Z., Naria M., Habib A., Abdin Z.U., Razzaq Chaudhry W., Akbar A. (2023) Effects of non-steroidal anti-inflammatory drugs (NSAIDs) and gastroprotective NSAIDs on the gastrointestinal tract: a narrative review. Cureus, 15(4), e37080. CrossRef Scholar google search
Bindu S., Mazumder S., Bandyopadhyay U. (2020) Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: a current perspective. Biochem. Pharmacol., 180, 114147. CrossRef Scholar google search
Pugachev M.V., Shtyrlin N.V., Agafonova M.N., Vasileva O.S., Fafanova E.M., Shtyrlin Yu.G. (2024) Synthesis and analgesic properties of prodrug bipharmacophore compounds based on pyridoxine and ketorolac. Uchenye Zapiski Kazanskogo Universiteta Seriya Estestvennye Nauki, 166(4), 608–622. CrossRef Scholar google search
Vasileva O.S., Agafonova M.N., Pugachev M.V., Malanyeva A.G., Shtyrlin Yu.G. (2025) Analgesic and anti-inflammatory properties of bipharmacophore prodrug derivatives based on pyridoxine and ketorolac. Uchenye Zapiski Kazanskogo Universiteta Seriya Estestvennye Nauki, 167(3), 371–384. CrossRef Scholar google search
Lea T. (2015) Caco-2 Cell Line. In: The Impact of Food Bioactives on Health: In Vitro and Ex Vivo Models (Verhoeckx K., Cotter P., López-Expósito I., Kleiveland C., Lea T., Mackie A., Requena T., Swiatecka D., Wichers H., eds.), Cham (CH): Springer. CrossRef Scholar google search
Chen G., Liu W., Yan B. (2022) Breast cancer MCF-7 cell spheroid culture for drug discovery and development. J. Cancer Ther., 13(3), 117–130. CrossRef Scholar google search
Telguziyeva Zh.A. (2009) Application of inhibitors of cyclooxygenase-2 in oncologic practice. Medicine and Ecology, 2(51), 18–22. Scholar google search
Kursov S.V., Nikonov V.V. (2016) Cyclooxygenase: physiological effects, inhibitors action and perspectives of paracetamol usage (analytical review). Emergency Medicine, 5(76), 27–35. CrossRef Scholar google search
Shostak N.A., Klimenko A.A., Demidova N.A., Anichkov D.A. (2020) Safety of selective non-steroidal anti-inflammatory drugs: analysis of the last years data. The Clinician, 14(1–2), 91–99. CrossRef Scholar google search
Bermejo M., Avdeef A., Ruiz A., Nalda R., Ruell J.A., Tsinman O., González I., Fernández C., Sánchez G., Garrigues T.M., Merino V. (2004) PAMPA — a drug absorption in vitro model 7. Comparing rat in situ, Caco-2, and PAMPA permeability of fluoroquinolones. Eur. J. Pharm. Sci., 21(4), 429–441. CrossRef Scholar google search
Sambuy Y., de Angelis I., Ranaldi G., Scarino M.L., Stammati A., Zucco F. (2005) The Caco-2 cell line as a model of the intestinal barrier: Influence of cell and culture-related factors on Caco-2 cell functional characteristics. Cell Biol. Toxicol., 21(1), 1–26. CrossRef Scholar google search
Artursson P., Karlsson J. (1991) Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem. Biophys. Res. Commun., 175(3), 880–885. CrossRef Scholar google search
Soeters P.B., Wolfe R.R., Shenkin A. (2019) Hypoalbuminemia: pathogenesis and clinical significance. J. Parenter. Enteral Nutr., 43(2), 181–193. CrossRef Scholar google search
Bourdon E., Blache D. (2001) The importance of proteins in defense against oxidation. Antioxid. Redox Signal., 3(2), 293–311. CrossRef Scholar google search
Mooney S., Leuendorf J.-E., Hendrickson C., Hellmann H. (2009) Vitamin B6: a long known compound of surprising complexity. Molecules, 14(1), 329–351. CrossRef Scholar google search
Saso L., Valentini G., Casini M.L., Grippa E., Gatto M.T., Leone M.G., Silvestrini B. (2001) Inhibition of heat-induced denaturation of albumin by nonsteroidal antiinflammatory drugs (NSAIDs): pharmacological implications. Arch. Pharm. Res., 24(2), 150–158. CrossRef Scholar google search
Ziesenitz V.C., Welzel T., van Dyk M., Saur P., Gorenflo M., van den Anker J.N. (2022) Efficacy and safety of NSAIDs in infants: a comprehensive review of the literature of the past 20 years. Pediatric Drugs, 24(6), 603–655. CrossRef Scholar google search
Vlad S.C., Miller D.R., Kowall N.W., Felson D.T. (2008) Protective effects of NSAIDs on the development of Alzheimer disease. Neurology, 70(19), 1672–1677. CrossRef Scholar google search
Kosmachevskaya O.V., Nasybullina E.I., Shumaev K.B., Chumikina L.V., Arabova L.I., Yaglova N.V., Obernikhin S.S., Topunov A.F. (2021) Dinitrosyl iron complexes with glutathione ligands intercept peroxynitrite and protect hemoglobin from oxidative modification. Appl. Biochem. Microbiol., 57(4), 411–420. CrossRef Scholar google search
Mahran R., Vello N., Komulainen A., Malakoutikhah M., Härmä H., Kopra K. (2023) Isothermal chemical denaturation assay for monitoring protein stability and inhibitor interactions. Sci. Rep., 13, 20066. CrossRef Scholar google search
Bennion B.J., Daggett V. (2003) The molecular basis for the chemical denaturation of proteins by urea. Proc. Natl. Acad. Sci. USA, 100(9), 5142–5147. CrossRef Scholar google search
